Daewoong Pharmaceutical Co. Ltd.

This study tracks 200 adults with type 2 diabetes to see if enavogliflozin helps them lose weight over 24 weeks. Participants take the drug as part of their normal care. The main goals are changes in body weight and BMI. This is an observational study, not a cure, but aims to imp…

This study looks at how well Envlo or Envlomet SR tablets control blood sugar and their safety in 15,000 adults with type 2 diabetes. Participants take the medication as prescribed by their doctor for 24 weeks. The main goal is to see changes in HbA1c, a key blood sugar measure.

This study looks at whether a mobile app called 'Well Check' can help people with type 2 diabetes better control their blood sugar, blood pressure, and weight. About 471 adults will use the app, which connects to their electronic health records, while their doctors monitor progre…